These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 8819811)

  • 1. Short-term development of transplant-related coronary artery disease in orthotopic cardiac allograft recipients.
    Albat B; Missov E; Serre I; Baldet P; Chaptal PA
    Minerva Cardioangiol; 1995 Oct; 43(10):435-8. PubMed ID: 8819811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients.
    Costanzo MR; Koch DM; Fisher SG; Heroux AL; Kao WG; Johnson MR
    J Heart Lung Transplant; 1997 Feb; 16(2):169-78. PubMed ID: 9059928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal.
    Mehra MR; Ventura HO; Chambers RB; Ramireddy K; Smart FW; Stapleton DD
    J Heart Lung Transplant; 1997 Jul; 16(7):743-51. PubMed ID: 9257256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection.
    Potena L; Holweg CT; Chin C; Luikart H; Weisshaar D; Narasimhan B; Fearon WF; Lewis DB; Cooke JP; Mocarski ES; Valantine HA
    Transplantation; 2006 Aug; 82(3):398-405. PubMed ID: 16906040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac operations in solid-organ transplant recipients.
    Mitruka SN; Griffith BP; Kormos RL; Hattler BG; Pigula FA; Shapiro R; Fung JJ; Pham SM
    Ann Thorac Surg; 1997 Nov; 64(5):1270-8. PubMed ID: 9386690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus infection in heart transplant recipients is associated with impaired endothelial function.
    Petrakopoulou P; Kübrich M; Pehlivanli S; Meiser B; Reichart B; von Scheidt W; Weis M
    Circulation; 2004 Sep; 110(11 Suppl 1):II207-12. PubMed ID: 15364864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic sensitization in recipients of left ventricular assist devices.
    John R; Lietz K; Schuster M; Naka Y; Rao V; Mancini DM; Rose EA; Smith CR; Oz MC; Edwards NM; Itescu S
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):578-91. PubMed ID: 12658200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some prognostic factors for the development of transplant-related coronary artery disease in human cardiac allografts.
    Stovin PG; Sharples L; Hutter JA; Wallwork J; English TA
    J Heart Lung Transplant; 1991; 10(1 Pt 1):38-44. PubMed ID: 1848788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group.
    Falagas ME; Snydman DR; Ruthazer R; Griffith J; Werner BG; Freeman R; Rohrer R
    Clin Transplant; 1997 Oct; 11(5 Pt 1):432-7. PubMed ID: 9361936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up after orthotopic heart transplantation.
    Heublein B; Haverich A; Borst HG
    Thorac Cardiovasc Surg; 1990 Oct; 38(5):285-90. PubMed ID: 2264036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation.
    Bonaros N; Dunkler D; Kocher A; Imhof M; Grimm M; Zuckermann A; Wolner E; Laufer G
    J Heart Lung Transplant; 2006 Sep; 25(9):1154-63. PubMed ID: 16962480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of cytomegalovirus infection, confirmed by pp65 antigen presence, on the development of cardiac allograft vasculopathy.
    Zakliczyński M; Krynicka-Mazurek A; Pyka Ł; Trybunia D; Nadziakiewicz P; Przybylski R; Zembala M
    Transplant Proc; 2007 Nov; 39(9):2866-9. PubMed ID: 18022004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac allograft vasculopathy after heart transplantation: risk factors and management.
    Valantine H
    J Heart Lung Transplant; 2004 May; 23(5 Suppl):S187-93. PubMed ID: 15093804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes in cardiac transplant recipients using allografts from older donors versus mortality on the transplant waiting list; Implications for donor selection criteria.
    Lietz K; John R; Mancini DM; Edwards NM
    J Am Coll Cardiol; 2004 May; 43(9):1553-61. PubMed ID: 15120811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late acute cardiac allograft rejection: new therapeutic options?
    Schweiger M; Wasler A; Prenner G; Tripolt M; Schwarz M; Tscheliessnigg KH
    Transplant Proc; 2005 Dec; 37(10):4528-31. PubMed ID: 16387161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart transplantation in diabetic recipients: a decade review of 161 patients at Columbia Presbyterian.
    Morgan JA; John R; Weinberg AD; Colletti NJ; Mancini DM; Edwards NM
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1486-92. PubMed ID: 15116012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.
    Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA
    J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.